Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.68
At close: Jun 20 EDT
$1.68
0.000.00%
Pre-Market: 4:04 AM EDT
Comments
Loading...
Artiva Biotherapeutics Analyst Ratings and Price Targets | NASDAQ:ARTV | Benzinga
Artiva Biotherapeutics Inc has a consensus price target of $18.14 based on the ratings of 8 analysts. The high is $21 issued by Jefferies on August 13, 2024. The low is $12 issued by HC Wainwright & Co. on June 11, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Needham, and Needham on June 11, 2025, May 15, 2025, and April 8, 2025, respectively. With an average price target of $17.67 between HC Wainwright & Co., Needham, and Needham, there's an implied 951.59% upside for Artiva Biotherapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Needham
HC Wainwright & Co.
Wedbush
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Artiva Biotherapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/11/2025 | Buy Now | 614.29% | HC Wainwright & Co. | Emily Bodnar39% | → $12 | Assumes | → Buy | Get Alert |
| 05/15/2025 | Buy Now | 971.43% | Needham | Gil Blum51% | $23 → $18 | Maintains | Buy | Get Alert |
| 04/08/2025 | Buy Now | 1269.05% | Needham | Gil Blum51% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2025 | Buy Now | 1090.48% | HC Wainwright & Co. | Edward White45% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2025 | Buy Now | 971.43% | Wedbush | Martin Fan 53% | $18 → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 03/25/2025 | Buy Now | 1090.48% | Cantor Fitzgerald | Josh Schimmer56% | $23 → $20 | Maintains | Overweight | Get Alert |
| 03/25/2025 | Buy Now | 1269.05% | Needham | Gil Blum51% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | 1090.48% | HC Wainwright & Co. | Edward White45% | → $20 | Initiates | → Buy | Get Alert |
| 11/13/2024 | Buy Now | 1269.05% | Needham | Gil Blum51% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/30/2024 | Buy Now | 1269.05% | Needham | Gil Blum51% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/13/2024 | Buy Now | 1269.05% | Needham | Gil Blum51% | → $23 | Initiates | → Buy | Get Alert |
| 08/13/2024 | Buy Now | 971.43% | Wedbush | David Nierengarten61% | → $18 | Initiates | → Outperform | Get Alert |
| 08/13/2024 | Buy Now | 1269.05% | Cantor Fitzgerald | Josh Schimmer56% | → $23 | Initiates | → Overweight | Get Alert |
| 08/13/2024 | Buy Now | — | TD Cowen | Tyler Van Buren44% | — | Initiates | → Buy | Get Alert |
| 08/13/2024 | Buy Now | 1150% | Jefferies | Kelly Shi43% | → $21 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Artiva Biotherapeutics (ARTV) stock?
The latest price target for Artiva Biotherapeutics (NASDAQ:ARTV) was reported by HC Wainwright & Co. on June 11, 2025. The analyst firm set a price target for $12.00 expecting ARTV to rise to within 12 months (a possible 614.29% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Artiva Biotherapeutics (ARTV)?
The latest analyst rating for Artiva Biotherapeutics (NASDAQ:ARTV) was provided by HC Wainwright & Co., and Artiva Biotherapeutics their buy rating.
When was the last upgrade for Artiva Biotherapeutics (ARTV)?
There is no last upgrade for Artiva Biotherapeutics
When was the last downgrade for Artiva Biotherapeutics (ARTV)?
There is no last downgrade for Artiva Biotherapeutics.
When is the next analyst rating going to be posted or updated for Artiva Biotherapeutics (ARTV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Artiva Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Artiva Biotherapeutics was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.
Is the Analyst Rating Artiva Biotherapeutics (ARTV) correct?
While ratings are subjective and will change, the latest Artiva Biotherapeutics (ARTV) rating was a with a price target of $0.00 to $12.00. The current price Artiva Biotherapeutics (ARTV) is trading at is $1.68, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
